Literature DB >> 9126610

Human cysteine-rich intestinal protein: cDNA cloning and expression of recombinant protein and identification in human peripheral blood mononuclear cells.

C Khoo1, R K Blanchard, V K Sullivan, R J Cousins.   

Abstract

Cysteine-rich intestinal protein (CRIP) is a small, 8.5-kDa protein with one double zinc-finger motif called a LIM domain. It is very abundant in intestine and some immune cells in rodents, and expression is influenced by development and the immune response. We have cloned a human CRIP cDNA from human small intestine poly(A)+ RNA by RT-PCR. Through sequencing, we found that the human intestinal CRIP protein (hCRIP) differed from the previously cloned rat CRIP by two amino acids (residues 8 and 58). hCRIP was expressed with the pET vector/bacterial system and isolated by gel filtration and ion-exchange chromatography. The protein was purified to homogeneity as confirmed by PAGE, Western blotting, and immunodetection. Recombinant hCRIP has a molecular mass of 8390 Da based on mass spectrum analysis. Southern analysis suggests that there are three copies of the CRIP gene in the human genome. hCRIP mRNA was detected by RT-PCR in human monocytes purified from peripheral blood and THP-1 cells, a human monocytic cell line. Incubation of THP-1 cells with 65Zn and chromatography of the cytosol show that a significant amount of the radioactivity is associated with CRIP as was shown previously for rat intestine. The results are consistent with a functional role for CRIP in proliferation/differentiation of specific cell types, particularly those associated with host defense.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126610     DOI: 10.1006/prep.1996.0709

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  6 in total

1.  MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.

Authors:  Benjamin Balluff; Sandra Rauser; Stephan Meding; Mareike Elsner; Cedrik Schöne; Annette Feuchtinger; Christoph Schuhmacher; Alexander Novotny; Uta Jütting; Giuseppina Maccarrone; Hakan Sarioglu; Marius Ueffing; Herbert Braselmann; Horst Zitzelsberger; Roland M Schmid; Heinz Höfler; Matthias P Ebert; Axel Walch
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

2.  Core cysteine residues in the Plasminogen-Apple-Nematode (PAN) domain are critical for HGF/c-MET signaling.

Authors:  Debjani Pal; Kuntal De; Carly M Shanks; Kai Feng; Timothy B Yates; Jennifer Morrell-Falvey; Russell B Davidson; Jerry M Parks; Wellington Muchero
Journal:  Commun Biol       Date:  2022-07-01

3.  Pseudogenes as Biomarkers and Therapeutic Targets in Human Cancers.

Authors:  Cristina Sisu
Journal:  Methods Mol Biol       Date:  2021

4.  Expressed pseudogenes in the transcriptional landscape of human cancers.

Authors:  Shanker Kalyana-Sundaram; Chandan Kumar-Sinha; Sunita Shankar; Dan R Robinson; Yi-Mi Wu; Xuhong Cao; Irfan A Asangani; Vishal Kothari; John R Prensner; Robert J Lonigro; Matthew K Iyer; Terrence Barrette; Achiraman Shanmugam; Saravana M Dhanasekaran; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Cell       Date:  2012-06-22       Impact factor: 41.582

5.  Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers.

Authors:  Jihua Hao; Adrian W R Serohijos; Gail Newton; Gina Tassone; Zuncai Wang; Dennis C Sgroi; Nikolay V Dokholyan; James P Basilion
Journal:  PLoS Comput Biol       Date:  2008-08-01       Impact factor: 4.475

6.  The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer.

Authors:  Natalie Ludyga; Sonja Englert; Kerstin Pflieger; Sandra Rauser; Herbert Braselmann; Axel Walch; Gert Auer; Heinz Höfler; Michaela Aubele
Journal:  Mol Cancer       Date:  2013-04-09       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.